EuroValve March 27 - 28, 2015 FINAL PROGRAM
Radisson BLU Hotel, Nice, FRANCE www.eurovalvecongress.com
Course directors Patrizio Lancellotti, Liege, Belgium Khalil Fattouch, Palermo, Italy Gilbert Habib, Marseille, France JosĂŠ Luis Zamorano, Madrid, Spain Raphael Rosenhek, Vienna, Austria Joint with ESC Working Group on Valvular Heart Disease Eucomed Code of Ethical Business Practice: COMPLIANT
Edito Welcome to EuroValve 2015! It is a great pleasure to welcome you for this third edition in the beautiful city of Nice, which offers something for everyone: whether you are a culture or art passionate, a Mediterranean cuisine lover, this amazing city is sure to please you. As you may know, we always intend to favour more interactivity and discussions, especially thanks to several symposia, industry symposia, controversies and round tables. Again, over 2 days, we will present an extensive program dedicated to valvular heart disease, focusing on genetics, surgery, epidemiology, transcatheter valve replacement, echocardiography, new imaging. This year, we are hosting the ePosters presentation on Friday March 27 at 16:15 in the exhibition hall. Do not forget to watch them on the interactive screens onsite in the exhibition hall. Take your time to visit the exhibition and discover the Industry news as it is only thanks to their precious help that we could achieve our ambitious program and do not miss Abbott Vascular and Sorin symposia on Saturday in the plenary room. We are very pleased to have you during two convivial days of fruitful teaching in Nice. Enjoy the congress! The EuroValve Directors Patrizo Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano and Raphael Rosenhek
Scientific Programme endorsed by the ESC Working Group on Valvular Heart Disease
Faculty Jutta BERGLER KLEIN, Vienna, Austria Eric BROCHET, Paris, France Bernard COSYNS, Braine-L’Alleud, Belgium Victoria DELGADO, Leiden, The Netherlands Alessandro DELLA CORTE, Naples, Italy Robert DION, Genk, Belgium Erwan DONAL, Rennes, France Gilles DREYFUS, Monaco Raluca Elena DULGHERU, Brussels, Belgium Filip DULGUEROU, Liege, Belgium Arturo EVANGELISTA MASIP, Barcelona, Spain Emile FERRARI, Nice, France Jacques GAUTHIER, Cannes, France Pierre GIBELIN, Nice, France Rocio HINOJAR, Madrid, Spain Bernard IUNG, Paris, France Philippe KOLH, Liege, Belgium
Giovanni La Canna, Milan, Italy Thierry LE TOURNEAU, Lille, France Julien MAGNE, Limoges, France David MESSIKA-ZEITOUN, Paris, France Thomas MODINE, Lille, France Mark MONAGHAN, London, United Kingdom Cécile OURY, Liege, Belgium Agnès PASQUET, Brussels, Belgium Philippe PIBAROT, Québec, Canada Luc PIERARD, Liege, Belgium Bernard PRENDERGAST, Oxford, United Kingdom Prakash P. PUNJABI, London, United Kingdom Guiseppe SPEZIALE, Bari, Italy Catherine SZYMANSKI, Amiens, France Pilar TORNOS, Barcelona, Spain Isidre VILACOSTA, Madrid, Spain
www.eurovalvecongress.com
EuroValve
Synoptic
March 27-28, 2015
Radisson BLU Hotel, Nice, FRANCE
FRIDAY MARCH 27 08:30 Opening ceremony
Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano, Raphael Rosenhek
08:45 Controversy in infective endocarditis: prophylaxis is no longer needed Patrizio Lancellotti, Gilbert Habib
09:30 Keynote lecture
SATURDAY MARCH 28 08:00 Controversy in secondary mitral regurgitation José Luis Zamorano, Luc Piérard
09:00 Keynote lecture José Luis Zamorano
09:30
José Luis Zamorano, Luc Piérard
10:00
Coffee break in the exhibition hall
10:30
Symposium: ascending aorta dilation 10:30 and aortic valve disease. Controversial issues in clinical practice 11:00 Giuseppe Speziale
symposium Improving patient outcome through innovation
Coffee break in the exhibition hall Improving risk stratification in asymptomatic severe aortic stenosis Patrizio Lancellotti, Raphael Rosenhek
12:00
Lunch break in the exhibition hall 12:15
13:00
Symposium: how to manage anticoagulant therapy in valve disease 13:15 Bernard Iung, Gilles Dreyfus
14:15 14:30
Symposium: what to do when prosthetic valves go wrong
symposium Mitral Regurgitation in the MitraClip Era
Lunch break in the exhibition hall
Clinical session: challenging clinical situation Gilbert Habib, Pierre Gibelin
Philippe Pibarot, Emile Ferrari
15:45
Coffee break in the exhibition hall
15:30 Challenging/controversial issues in the management VHD Philippe Kolh
16:15
Pulmonary hypertension (PHT) in valvular heart disease Bernard Prendergast, Philippe Pibarot
17:45
ePosters competition in the exhibition hall Jury: Raphael Rosenhek José Luis Zamorano
Case presentations: challenges in heart valve diseases Victoria Delgado, Erwan Donal, Jacques Gauthier
19:00
End of the sessions
16:50 Closing remarks / ePosters awards ceremony Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano, Raphael Rosenhek
Friday March 27, 2015 08:00
Welcome coffee in the exhibition hall
08:30 Opening ceremony Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano, Raphael Rosenhek
08:45
Controversy in infective endocarditis: prophylaxis is no longer needed
Patrizio Lancellotti, Gilbert Habib
08:45 Pro, Bernard Prendergast 09:00 Contra, Bernard Iung 09:15 Round table discussion with experts panel, Isidre Vilacosta, José Luis Zamorano
09:30
Keynote lecture
José Luis Zamorano, Luc Piérard
09:30 Why is mitral regurgitation so important in heart failure? And how do we fix it?
Robert Dion
10:00
Coffee break in the exhibition hall
10:30 Symposium: ascending aorta dilation and aortic valve disease. Controversial issues in clinical practice
Giuseppe Speziale
10:30 Follow-up of ascending aorta diameter by multimodality imaging.
Which test and when? Arturo Evangelista 10:50 Comparison of aortic growth rate in bicuspid aortic valve, Marfan syndrome
and degenerative aortopathy, Agnès Pasquet 11:10 Prophylactic aorta surgery at 45-55mm Which risk factors?
Alessandro Della Corte 11:30 Surgical strategies in different conditions, Giovanni La Canna 11:50 Round table discussion with experts panel, Arturo Evangelista Masip,
Khalil Fattouch, Raphael Rosenhek
12:00
Lunch break in the exhibition hall
13:00 Symposium: how to manage anticoagulant therapy in valve disease
Bernard Iung
13:00 After valve replacement, Bernard Iung 13:15 In infective endocarditis, Bernard Prendergast 13:30 Before and during pregnancy, Bernard Iung 13:45 Is there a place for new anticoagulants in prosthetic valves? Patrizio Lancellotti 14:00 Round table discussion with experts panel, Bernard Cosyns, Philippe Kolh, Cécile Oury
14:30 Symposium: what to do when prosthetic valves go wrong
Philippe Pibarot, Emile Ferrari
14:30 Patient-prosthesis mismatch or prosthetic valve stenosis – which is it?
Philippe Pibarot 14:45 Valve-in-valve intervention for degenerating bioprosthesis, Giovanni La Canna 15:00 Percutaneous closure of paravalvular leaks, José Luis Zamorano 15:15 Valve thrombosis – how to choose the least worst treatment option,
Bernard Cosyns 15:30 Round table discussion with experts panel, Julien Magne, José Luis Zamorano 15:45
Coffee break in the exhibition hall
16:15 Pulmonary hypertension (PHT) in valvular heart disease ePosters competition in the exhibition hall Bernard Prendergast, Philippe Pibarot Jury: 16:15 PHT in primary MR, Catherine Szymanski Raphael Rosenhek 16:35 PHT in aortic stenosis, Thierry Le Tourneau José Luis Zamorano 16:55 Exercise PHT in valvular heart disease, Julien Magne 17:15 PHT following surgery for valvular heart disease, Rocio Hinojar
17:45 Case presentations: challenges in heart valve diseases
Victoria Delgado, Erwan Donal, Jacques Gauthier
17:45 A high-risk patient with aortic stenosis: how far should we go?
Bernard Prendergast 18:00 An asymptomatic patient with severe mitral regurgitation, Raphael Rosenhek 18:15 A patient with high gradient on a prosthetic valve, Bernard Cosyns 18:30 A difficult diagnosis of infective endocarditis, Gilbert Habib 18:45 Round table discussion: The youth challenging the experts, Julien Magne,
Raluca Dulgheru
19:00
End of the sessions
Saturday March 28, 2015 07:30
Welcome coffee in the exhibition hall
08:00
Controversy in secondary mitral regurgitation
José Luis Zamorano, Luc Piérard
08:00 Repair, Khalil Fattouch 08:20 Replace, Prakash P. Punjabi 08:40 Round table discussion with experts panel, Bernard Iung, Philippe Kolh
09:00
Keynote lecture
José Luis Zamorano
09:00 State-of-the-art on transcatheter mitral valve procedures, Giovanni La Canna 09:20 Round table discussion with experts panel, Thomas Modine, Gilbert Habib,
Robert Dion
09:30
symposium Improving patient outcome through innovation
Alain Berrebi, Khalil Fattouch
09:30 09:50 10:10
New generation stented vales: the Crown PRT, Martin Hartrumpf Latest generation of surgical valves: the Sutureless Solution for AVR, Bart Meuris Innovation in mitral repair: the Memo 3D Rechord, Xavier Ruya
10:30
Coffee break in the exhibition hall
11:00
Improving risk stratification in asymptomatic severe aortic stenosis
Patrizio Lancellotti, Raphael Rosenhek 11:00 Exercise testing and stress echo, Raluca Dulgheru 11:15 Valve calcification by CT, David Messika-Zeitoun 11:30 Neuro-hormones, Jutta Bergler-Klein 11:45 Myocardial fibrosis by MRI, Victoria Delgado 12:00 Round discussion with experts panel, Cécile Oury, Julien Magne
12:15
symposium Mitral regurgitation in the MitraClip Era
José Luis Zamorano, Patrizio Lancellotti
12:15 Introduction, Patrizio Lancellotti 12:18 What has changed since the introduction of MitraClip therapy? José Luis Zamorano 12:30 Patient selection for MitraClip therapy, Gilbert Habib 12:42 Patient management during and after MitraClip therapy, Eric Brochet 12:54 MitraClip therapy clinical evidence & trial program, Victoria Delgado 13:06 Discussion, Patrizio Lancellotti 13:10 Conclusion, Patrizio Lancellotti
13:15
Lunch break in the exhibition hall
14:15
Clinical session: challenging clinical situation
Gilbert Habib, Pierre Gibelin
14:15 A case of large vegetation with neurological complication, Isidre Vilacosta 14:30 A case of prosthetic valve endocarditis, Eric Brochet 14:45 A case of urgent surgery, Khalil Fattouch 15:00 Round discussion with experts panel, Bernard Cosyns, Raphael Rosenhek
15:30
Challenging/controversial issues in the management of VHD
Philippe Kolh
15:30 Low gradient severe aortic stenosis, Philippe Pibarot 15:50 Left-sided severe valvular disease with concomitant tricuspid regurgitation,
Filip Dulguerou 16:10 Staged approach in high risk patients with severe AS: BAV and then
TAVR? Mark Monaghan 16:30 Round discussion with experts panel, Jutta Bergler-Klein, Bernard Iung
16:50 Closing remarks / ePosters awards ceremony Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, JosĂŠ Luis Zamorano, Raphael Rosenhek
ePosters competition 16:15 Preoperative and predis charge predictors for persistent pulmonary hypertension after mitral valve surgery in patients with chronic organic mitral regurgitation Ariani Rina, Amiliana Soesanto Departement of Cardiology and Vascular Medicine Medical Faculty University of Indonesia, National cardiovascular center Harapan Kita, Jakarta, Indonesia
16:18 Reduction of pulmonary vascular resistance after mitral valve surgery in mitral stenosis patient with pulmonary hypertension improves heart rate recovery during exercise test Nurdin Mochamad Hilal, Andang Joesoef, Renan Sukmawan, Amiliana Mardiani Soesanto Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia
16:21 Comparison of force development of right atrial and left atrial human skinned fibers Constanze Bening, Lars Oliver Conzelmann, Uwe Mehlhorn, Christian-Friedrich Vahl University Hospital, Department of Cardiothoracic and Vascular Surgery, Mainz, Germany
16:24 Baseline ejection fraction is the major determinant of clinical and functional improvement at 1-year follow-up after Trans Aortic Valve Implantation (TAVI) Sara Cimino, Martina Solli, Manuela Reali, Valentina Petronilli, Francesco Cicogna, Elisa Silvetti, Tiziana Salatino, Mauro Pennacchi, Gennaro Sardella, Luciano Agati Department of Cardiology, “Sapienza� University, Rome, Italy
16:27 Pre operative endothelin-1 level correlates with systolic pulmonary artery pressure after mitral valve surgery in patients with mitral stenosis Dyna Evalina Syahlul, Amiliana Mardiani Soesanto, Suko Adiarto Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia National Cardiovascular Center Harapan Kita, Jakarta, Indonesia, Jakarta, Indonesia
16:30 Infective endocarditis complicated by renal failure: etiology and prognosis: role of renal biopsy Ichrak Boukantar, Ilham Bensahi, Chaymaa Houari, Rachida Habbal CHU Ibn Rochd, Casablanca, Morocco
16:33 Prevalence of coronary artery disease before valvular surgery in moroccan patients with rheumatic valvular disease Ilham Bensahi, Salim Arous, Leila Azzouzi, Rachida Habbal Department of Cardiology, University Hospital Ibn Rochd of Casablanca, Morocco
16:36 Effect of preload reduction by nitroglycerine on the severity of ischemic mitral regurgitation and mitral apparatus geometry: difference between anterior and inferior myocardial infarction assessed by three-dimensional echocardiography Cho In-Jeong, Chi Young Shim, Geu-Ru Hong, Namsik Chung, Jong-Won Ha Severance Cardiovascular Hospital, Seoul, Korea, Republic of South Korea
Friday March 27, 2015 16:39 Dramatic decrease in staphylococcus aureus infective endocarditis early mortality using a new strickly applied protocol L. Olivier, M. Jamme, Jean-Paul Casalta, Ludivine Saby, Sandrine Hubert, Erwan Salaun, Cécile Lavoute, Gilbert Habib, Didier Raoult La Timone Hospital, Marseille, France
16:42 Evolution of 18F-FDG PET/CT findings under therapy infective endocarditis: first description Eleonore Ravis, Laetitia Tessonnier, Sandrine Hubert, Cécile Lavoute, Ludivine Saby, Erwan Salaun, Jean-Paul Casalta, Serge Camilleri, Gilbert Habib La Timone Hospital, Marseille, France
16:45 A positive 18F-FDG PET/CT predicts new embolic events in infective endocarditis Eleonore Ravis, Laetitia Tessonnier, Sandrine Hubert, Cécile Lavoute, Ludivine Saby, Erwan Salaun, Jean-Paul Casalta, Serge Camilleri, Gilbert Habib La Timone Hospital, Marseille, France
16:48 A transcatheter mitral paravalvular leak closure complicated by AVP III device embolization
Agnè Drasutiene
Notes ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ......................................................................
Opening a window on the heart with VFM Assess cardiovascular blood flow distribution without angle dependency with Hitachi-Aloka’s Vector Flow Mapping
www.hitachi-medical-systems.com
Information Congress venue: Radisson blu Hotel, Nice, FRANCE 223, promenade des Anglais - 06 200 Nice Tel. +33 (0)4 97 17 7050 www.radissonblu.fr/hotel-nice REGISTRATION DESK OPENING HOURS Friday March 27 Saturday March 28
07.30 - 19.00 07.30 - 17.00
EVENT COORDINATORS’CONTACTS Project manager Stéphanie Meyer
+ 33 646 10 48 26
Managing director Vérane Bergeron Moreau + 33 621 78 87 16
Stay alert Keep up to date with the highest quality material, both scientific and clinical, from all areas of cardiovascular imaging with email table of contents alerts from the European Heart Journal – Cardiovascular Imaging
At the heart of Cardiology Sign up under the ‘Stay Alert’ heading at: ehjcimaging.oxfordjournals.org
Exhibition hall Office
Cloakroom
Toilets Lifts 7
LEVEL -1
1
REGISTRATION DESK
AUDITORIUM
Stairs 6
BUFFET
2
5
BUFFET
Posters BUFFET
Preview FUTUR MEETING TABLE
4
Booth Company 1 2 3 4
Booth Company
Sorin Group Daiichi Sankyo
Philips EACVI
5 6 7
GE Healthcare Medtronic Hitachi
3
EXHIBITION TIMES Friday March 27 Saturday March 28
08.00 - 19.00 07.30 - 14.00
ACKNOWLEDGEMENTS 2015
Notes ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ......................................................................
Sorin Group has the pleasure of inviting you to attend the Industry Symposium:
IMPROVING PATIENT OUTCOME THROUGH INNOVATION WITHIN THE SCIENTIFIC PROGRAM OF EUROVALVE 2015 CONGRESS
SYMPOSIUM PROGRAM 09:30 am - 09:50 am NEW GENERATION STENTED VALVES: THE CROWN PRT M. Hartrumpf, Germany 09:50 am - 10:10 am LATEST GENERATION OF SURGICAL VALVES: THE SUTURELESS SOLUTION FOR AVR B. Meuris, Belgium 10:10 am - 10:30 am INNOVATION IN MITRAL REPAIR: THE MEMO 3D RECHORD X. Ruya, Spain
INDUSTRY SYMPOSIUM Saturday, March 28, 2015 9:30 am - 10:30 am RADISSON BLU HOTEL NICE - FRANCE
www.eurovalvecongress.com ORGANIZATION: divine [id] agency • Stéphanie Meyer: smeyer@divine-id.com • Mob. +33 (0) 646 10 48 26 •V érane Bergeron Moreau: vbergeron@divine-id.com • 17, rue Venture - 13001 Marseille, France • Tel. +33 (0) 491 57 19 60 • Fax +33 (0) 491 57 19 61 • www.divine-id.com